Stockscreener 앱 받기
37.81
2.60%
-1.01
전일 마감가:
$38.82
열려 있는:
$39.05
하루 거래량:
2.05M
Relative Volume:
0.64
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-5.17%
1개월 성능:
-2.00%
6개월 성능:
+15.87%
1년 성능:
+45.26%
1일 변동 폭
$37.68
$39.24
1주일 범위
$37.68
$39.70
52주 변동 폭
$22.73
$44.47
ARK Genomic Revolution ETF Stock (ARKG) Company Profile
명칭
ARK Genomic Revolution ETF
전화
855-406-1506
주소
-
Compare ARKG vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ARKG
ARK Genomic Revolution ETF
|
37.81 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
364.80 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
738.93 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
742.36 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
295.32 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
684.23 | 124.43B | 0 | 0 | 0 | 0.00 |
ARK Genomic Revolution ETF 주식(ARKG)의 최신 뉴스
Tempus AI Inc (TEM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
How is ARKG Performing in the Current Market Environment - Kavout | AI
Cathie Wood’s ARK sells Figma stock, buys Scribe Therapeutics By Investing.com - Investing.com Nigeria
BioNTech’s Pumitamig Hopes Face a Reality Check as ARK Exits and the Stock Hovers at a Technical C - AD HOC NEWS
1ARG ETF Profile: Dividends, Returns (LSE:1ARG) - TradingView
A408AY ETF Profile: Dividends, Returns (LS:A408AY) - TradingView
Cathie Wood Sells HOOD, Buys More SPCX: What ARK's Latest Moves SignalARK Innovation ETF (BATS:ARKK) - Benzinga
🧬 DNA Stock | Is Ginkgo Bioworks The Next Amazon Stock? Eswatini (usFV0zKJfR) - Mshale
Cathie Wood’s ARK Sells HOOD Stock Again – Even As Robinhood Hits 1M Gold Cards, Launches Platinum Card - TradingView
More NTLA, Less RKLB: Cathie Wood’s Latest ARK Trades Explained - Stocktwits
How (ARKG) Movements Inform Risk Allocation Models - Stock Traders Daily
Cathie Wood's $362 Million CRISPR Therapeutics Bet Isn't Just Bold -- It's Backed by a Catalyst Many Investors Are Underrating - The Motley Fool
Cathie Wood's $362 Million CRISPR Therapeutics Bet Isn't Just Bold -- It's Backed by a Catalyst Many Investors Are Underrating - The Motley Fool
Cathie Wood's Ark Invest sold $7.4 million of BioNTech stock - MSN
Cathie Wood buys $2 million of tumbling AI stock - MSN
ARKG and GNOM ETFs offer different genomic bets with varied risk and returns in 2026. - Pluang
ETF Showdown: ARKG vs GNOM, Which Genomics Fund Wins? - Yahoo Finance
These 15 Funds Cost Investors Billions Over the Past Decade - Morningstar
ARG1 ETF Profile: Dividends, Returns (FWB:ARG1) - TradingView
ETFs Investing in GeneDx Holdings Corp. Class A Stocks - TradingView
ARG1 ETF Profile: Dividends, Returns (MUN:ARG1) - TradingView
Cathie Wood’s ARK Invest adds another $57M to SpaceX, sells $39M stake in AMD - Seeking Alpha
Cathie Wood Just Bet Big on This Biotech Stock - webull.com
Cathie Wood Dumps $11.7 Million in AMD, Redirects Capital to SpaceX and CoreWeave - finance.biggo.com
ATAI Stock Slips After Blockbuster Week: Cathie Wood Calls $3.8B Lilly Deal ‘Well-Deserved’ Return For Shareholders - TradingView
Cathie Wood's Ark Invest in broad sell-off; trims AI, crypto, internet names - MSN
ARKG ETF Profile: Dividends, Returns (VANTAGE:ARKG) - TradingView
Cathie Wood is selling this high-flying stock. Is it a buy? - MSN
Cathie Wood Is Selling This High-Flying Stock. Is It a Buy? - The Motley Fool
ARKGCO ETF Profile: Dividends, Returns (BVC:ARKGCO) - TradingView
AAKG ETF Profile: Dividends, Returns (TRADEGATE:AAKG) - TradingView
AAKG ETF Profile: Dividends, Returns (DUS:AAKG) - TradingView
Cathie Wood's Ark Invest Sold $7.4 Million of BioNTech Stock - AOL.com
Cathie Wood is loading up on this biotech stock. Is it a no-brainer buy? - MSN
ARG1 ETF Profile: Dividends, Returns (XETR:ARG1) - TradingView
Cathie Wood Sold $8 Million of AMD Stock in a Single Day - AOL.com
AAKG ETF Profile: Dividends, Returns (GETTEX:AAKG) - TradingView
What This $1.1 Million Insider Sale at Accelerant Means for Investors - AOL.com
AAKG ETF Profile: Dividends, Returns (XETR:AAKG) - TradingView
AAKG ETF Profile: Dividends, Returns (HAM:AAKG) - TradingView
Cathie Wood Is Loading Up on This Biotech Stock. Is It a No-Brainer Buy? - The Motley Fool
AAKG ETF Profile: Dividends, Returns (HAN:AAKG) - TradingView
ARKG ETF Profile: Dividends, Returns (SIX:ARKG) - TradingView
Cathie Wood reshuffles portfolio ahead of Q2, buys SpaceX, Eli Lilly, Meta; pares AMD, Roku (ARKK:BATS) - Seeking Alpha
Ark Invest buys $21.3 million of SpaceX stock, trims AMD holdings - scanx.trade
ARK Genomic Revolution ETF (ARKG) 재무 분석
ARK Genomic Revolution ETF (ARKG)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.36%
0.42%
자본화:
|
볼륨(24시간):